ClinicalTrials.gg
RecruitingNCT07049757Updated Jun 4, 2026

Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities

An interventional study of Smoking cessation education and Survey Administration in Tobacco-Related Carcinoma and Smoking Cessation, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
760
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Smoking Cessation by University of California, San Francisco — 5 open to participants now, 6 under way, none of them phase 3. Smoking Cessation · University of California, San Francisco.

Planned enrollment
5th of 38
760 · median 174
Started
2026
the only one that year
No phase
31 of 39
5 open now
Registered
36th of 39
by date

Among the 39 studies in Smoking Cessation by University of California, San Francisco, this one is the 5th largest by planned enrollment of the 38 interventional ones that give a count, is the only one that started in 2026, is one of 31 with no phase, and was the 36th registered.

Smoking Cessation

1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.

Browse Smoking Cessation studies →

Open to participants now

5 of the 39 studies in Smoking Cessation by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 134 Smoking Cessation studies recruiting now, 92 (69%) set no upper age limit and 35 (26%) stop at 75 or younger; 6 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Smoking Cessation by University of California, San Francisco, or all of them as a file.
02

Study summary

This study evaluates whether the Smokefree Family Living (SFL) intervention improves quit rates (smoking cessation) and exposure to tobacco contamination that stays in items such as, carpets, walls, and furniture, even after the smoke has cleared (third-hand smoke (THS)) among Chinese American smokers and their non-smoking household members. Smoking remains high among Chinese American males with limited ability to speak English. This causes the non-smoking household members to be exposed to THS, which contains many of the same harmful components as smoking and becomes more toxic as it ages. SFL is tailored for Chinese Americans and combines the contents of the Quit Smoking for a Healthy Family (QS) intervention with additional THS education and cleaning strategies. QS focuses on smoking cessation through educational sessions and support. THS education and cleaning strategies provide information on THS and how to clean the home for THS. SFL may help Chinese American smokers and their non-smoking household members learn about the importance of quitting and the dangers of THS, this may improve smoking cessation and reduce THS exposure

Read the detailed description

PRIMARY OBJECTIVES:

I. Integrate the original "Quit Smoking for a Healthy Family" (QS) curriculum with the third-hand smoke education and cleaning intervention (THS) into a new intervention titled "Smokefree Family Living" (SFL) for Chinese immigrant families and household members.

II. Examine the efficacy of SFL by measuring smoking cessation rates at six months and the reduction in third-hand smoke exposure among smokers and nonsmoking household member participants, respectively, using a 2-arm randomized trial targeting 320 smoker-household member dyads from the Chinese American communities.

SECONDARY OBJECTIVE:

I. Examine individual and social pathways mediating the outcomes for cessation attempts, abstinence, and tobacco smoke exposure.

EXPLORATORY OBJECTIVES:

I. Explore the long-term impacts of the THS education and the timing of the accessibility of the THS intervention by examining time to first 30-day quit attempts and duration of quit attempts after exposure to THS intervention in both intervention groups of a subsample available for 12-month follow-up.

II. To compare the long-term efficacy of the SFL and QS interventions in sustaining smoking cessation and reducing tobacco smoke exposure.

III. To evaluate the feasibility and effectiveness of using silicone wristbands to measure third-hand smoke (THS) exposure among non-smoking household members of Chinese American smokers participating in the study.

IV. Assess the behavioral changes related to smoking and smoke exposure, as well as the psychosocial impact of the interventions on participants and their household members.

OUTLINE:

A family-based intervention development phase prior to the randomized study will integrate the original "Quit Smoking for a Healthy Family" (QS) curriculum of the Healthy Family Project with the third-hand smoke education and cleaning intervention (THS) into a newly integrated intervention named "Smokefree Family Living" (SFL) for Chinese immigrant families and household members. Information collected from this group will be used to refine and develop the final SFL intervention used in the subsequent clinical trial. These participants will not be included in final study analyses.

Participants enrolled after the focus group data has been evaluated for implementation will be randomized to 1 of 2 arms.

Arm I: Participants attend two QS educational sessions over 45-60 minutes one month apart and receive two follow-up phone calls over 15-30 minutes 1-2 weeks after each session over 6 weeks. Participants also receive a Healthy Family Action Plan as well as a smoking cessation resource guide and set goals on study. Participants then receive THS education and cleaning strategies at 6 months. Additionally, participants undergo urine sample collection throughout the study.

Arm II: Participants attend two QS educational sessions over 45-60 minutes one month apart and receive two follow-up phone calls over 15-30 minutes 1-2 weeks after each session over 6 weeks. During the second QS educational session, participants receive THS education and cleaning strategies. Participants also receive a Healthy Family Action Plan as well as a smoking cessation resource guide and set goals on study. Additionally, participants undergo urine sample collection throughout the study.

After completion of study intervention, participants are followed up at 6 and 12 months.

03

Conditions studied

  • Tobacco-Related Carcinoma
  • Smoking Cessation

Browse trials for

Keywords

  • Third-hand Smoke
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All Participants (Lay Health Workers, Smokers, Family Participants, and Post-Trial Household Member Group Interview Participants):

  1. Must be 18 years of age or older.
  2. Must self-identify as Chinese or of Chinese descent (ethnic or cultural identification, not national origin).
  3. Must be able to understand in spoken Chinese (Cantonese and/or Mandarin) or English.
  4. Able to attend educational sessions in person or via video conferencing.
  5. Ability to understand and the willingness to sign a written document.
  6. Have a mobile phone that can receive Short Message Service (SMS) text messages, or an email address and a phone number where they can be reached by the study team.

Lay Health Workers:

  1. Must have experience or interest in community outreach and education.
  2. Must demonstrate proficiency in language (Cantonese and/or Mandarin or English) sufficient to deliver study materials and interact with participants.
  3. Must be affiliated with the Chinese Community Health Resource Center (CCHRC) or recruited through community networks.
  4. Must agree to participate in training and intervention delivery activities as outlined in the study protocol.

Smokers (Participants who are current smokers):

  1. Must have smoked within the past 30 days, either daily or occasionally.
  2. Must have a non-smoking household member.

Family Participants (Non-smoking family/household members):

  1. Must live in the same household as the smoker participant.
  2. Must not have used any tobacco products in the past 30 days.

Post-Trial Household Member Group Interview Participants:

1. Living in the same household with the smoker-household member dyad participant being interviewed or considered as a household member.

Exclusion criteria

Exclusion Criteria:

Lay Health Workers, Smokers (Participants who are current smokers) and Family Participants (Non-smoking Family/household members):

  1. Currently participating in another smoking cessation program.
  2. Non-residents of California.
  3. Participants unwilling to provide follow-up contact for assessments at 6 and 12 months.

Lay Health Workers:

  1. Lack of willingness or ability to complete training or deliver intervention sessions as required by the study protocol.
  2. Inability to maintain confidentiality and professionalism during interactions with study participants.
  3. Active participation in conflicting research studies or programs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
760 participants (estimated)

Study arms

  • Experimental
    Intervention Development (Focus group + Interview)

    To achieve information gathering and preliminary adaptation design to prepare for the randomized clinical trial, focus groups and individual interviews with 24 participants (6 Chinese current smokers; 6 former smokers who have stopped smoking within the past 2 years; and 12 family/household members living with a current/former smoker) to review the newly developed or updated intervention materials. The Community Advisory Board (CAB) will also be involved in providing input.

    Other: Focus Group

  • Active comparator
    Arm I: Quit Smoking for a Healthy Family Group (QS)

    Participants attend two QS educational sessions over 45-60 minutes one month apart and receive two follow-up phone calls over 15-30 minutes 1-2 weeks after each session over 6 weeks. Participants also receive a Healthy Family Action Plan as well as a smoking cessation resource guide and set goals on study. Participants then receive THS education and cleaning strategies at 6 months after the initial QS curriculum. Additionally, participants undergo urine sample collection throughout the study and non-smoking family/household members will wear a silicone wristband for 2 days at each assessment.

    Other: Smoking cessation education · Behavioral: Survey Administration · Behavioral: Telephone-Based Intervention · Procedure: Urine Specimen Collection · Other: Silicone Wrist Band · Other: Interview

  • Experimental
    Arm II: Smokefree Family Living Group (SFL)

    Participants attend two QS educational sessions over 45-60 minutes one month apart and receive two follow-up phone calls over 15-30 minutes 1-2 weeks after each session over 6 weeks. During the second QS educational session, participants receive THS education and cleaning strategies. Participants also receive a Healthy Family Action Plan as well as a smoking cessation resource guide and set goals on study. Additionally, participants undergo urine sample collection throughout the study and non-smoking family/household members will wear a silicone wristband for 2 days at each assessment.

    Other: Smoking cessation education · Behavioral: Survey Administration · Behavioral: Telephone-Based Intervention · Procedure: Urine Specimen Collection · Other: Silicone Wrist Band · Other: Interview

Interventions

  • OtherSmoking cessation education

    Quit Smoking for a Healthy Family (QS) and Smokefree Family Living (SFL) education sessions to promote smoking cessation and reduce tobacco smoke exposure.

    Also known as: Education for Intervention, Intervention by Education, Intervention through Education

  • BehavioralSurvey Administration

    Administered for ancillary studies

    Also known as: Questionnaires

  • BehavioralTelephone-Based Intervention

    Participants will receive follow-up calls

    Also known as: Telephone-Based Follow-up

  • ProcedureUrine Specimen Collection

    Undergo urine sample collection at baseline

    Also known as: Urine Sample

  • OtherSilicone Wrist Band

    Non-smoking family/household members will wear a silicone wristband for 2 days at each assessment for ancillary studies

  • OtherInterview

    Selected participants will take part in an interview for ancillary studies

    Also known as: In-depth interview

  • OtherFocus Group

    Participants will review and comment on materials under development to be used in randomized clinical trial.

06

What researchers measure

Primary outcomes

  1. Proportion of participants who have quit smoking at 6 months

    The smoking cessation rate is defined as the proportion of smokers who report quitting smoking, with biochemically verified 30-day point prevalent abstinence at the 6-month follow-up. Smoking rates will be reported by arm.

    Time frame: 6 months

Secondary outcomes

  1. Change in levels of tobacco smoke biomarkers for second-(SHS)hand smoke exposure

    The change in level of tobacco smoke exposure will be assessed among non-smoking family/household members by reviewing levels of urinary 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) at baseline and at 6 months.

    Time frame: Up to 6 months

  2. Proportion of participants who have quit smoking at 12 months

    The smoking cessation rate is defined as the proportion of smokers who report quitting smoking, with verified 30-day point prevalent abstinence by biochemical markers (e.g., urinary NNAL and cotinine tests) at the 12-month follow-up. Smoking rates will be reported by arm.

    Time frame: Up to 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Mar 2028, 24 months after the start.

Of 547 non-industry interventional studies with no phase under Smoking Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 24 months is close to that.

Counting every sponsor, half of 564 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Jul 3, 2025
StartActual
Mar 23, 2026
Primary completionEst.
Mar 31, 2028
CompletionEst.
Sep 30, 2028
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07049757
Collaborators
Tobacco Related Disease Research Program
Responsible party
Sponsor
First posted
Jul 3, 2025
Start date
Mar 23, 2026
Primary completion
Mar 31, 2028 (estimated)
Completion
Sep 30, 2028 (estimated)
Last update
Jun 4, 2026

Study contacts

Edgar Yu
Contact
edgar.yu@ucsf.edu
877-827-3222
Janice Tsoh, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion